|
|
| Line 1: |
Line 1: |
| {{Family tree/start}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; width: 220px; height: 140px;| | | | | | | | | | | | | B01 | | | | | | | | | | | | | |B01=
| |
| <center>'''Symptoms & Signs'''</center><br>
| |
| ----
| |
| ❑ Altered mental status<br>
| |
| ❑ Clammy skin ± cyanosis<br>
| |
| ❑ Hypotension (MAP <70 mmHg)<br>
| |
| ❑ Oliguria (urine output <0.5 mL/kg/h)<br>
| |
| ❑ Tachycardia (heart rate >100 bpm)}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; height: 20px; | | | | | | | | | | | | | B02 | | | | | | | | | | | | | |B02=
| |
| <center>'''Shock'''</center>}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: left; height: 100px; | | | | | | | | | | | | | B03 | | | | | | | | | | | | | |B03=
| |
| <center>'''Ventilate—Infuse—Pump (VIP)'''<ref name="Weil-1969">{{Cite journal | last1 = Weil | first1 = MH. | last2 = Shubin | first2 = H. | title = The VIP approach to the bedside management of shock. | journal = JAMA | volume = 207 | issue = 2 | pages = 337-40 | month = Jan | year = 1969 | doi = | PMID = 5818156 }}</ref><ref name="Vincent-2013">{{Cite journal | last1 = Vincent | first1 = JL. | last2 = De Backer | first2 = D. | title = Circulatory shock. | journal = N Engl J Med | volume = 369 | issue = 18 | pages = 1726-34 | month = Oct | year = 2013 | doi = 10.1056/NEJMra1208943 | PMID = 24171518 }}</ref>
| |
|
| |
|
| </center>
| |
| ----
| |
| ❑ Intubation with mechanical ventilation<br>
| |
| ❑ Normal saline 0.5–1 L q10–15 min<sup>†</sup><br>
| |
| ❑ Norepinephrine 0.1–2.0 μg/kg/min}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: left; height: 200px; | | | | | | | | | | | | | B04 | | | | | | | | | | | | | |B04=
| |
| <center>'''Workups'''</center>
| |
| ----
| |
| ❑ CBC/DC/SMA-7/PT/PTT<br>
| |
| ❑ Arterial blood gas<br>
| |
| ❑ Lactate<br>
| |
| ❑ ECG<br>
| |
| ❑ CXR<br>
| |
| ❑ Echocardiography<br>
| |
| ❑ Central venous catheter<br>
| |
| ❑ Pulmonary artery catheter}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: left; height: 260px; | | | | | | | | | | | | | B05 | | | | | | | | | | | | | |B05=
| |
| <center>'''Immediate Goals'''<ref name="Dellinger-2013">{{Cite journal | last1 = Dellinger | first1 = RP. | last2 = Levy | first2 = MM. | last3 = Rhodes | first3 = A. | last4 = Annane | first4 = D. | last5 = Gerlach | first5 = H. | last6 = Opal | first6 = SM. | last7 = Sevransky | first7 = JE. | last8 = Sprung | first8 = CL. | last9 = Douglas | first9 = IS. | title = Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. | journal = Crit Care Med | volume = 41 | issue = 2 | pages = 580-637 | month = Feb | year = 2013 | doi = 10.1097/CCM.0b013e31827e83af | PMID = 23353941 }}</ref></center>
| |
| ----
| |
| ❑ MAP >65–70 mmHg<br>
| |
| ❑ CVP 8–12 mmHg<br>
| |
| ❑ PCWP 12–15 mmHg<br>
| |
| ❑ CI >2.1 L/min/m<sup>2</sup><br>
| |
| ❑ Sa<sub>O<sub>2</sub></sub> >90%–92%<br>
| |
| ❑ M<sub>VO<sub>2</sub></sub> >60%<br>
| |
| ❑ S<sub>CVO<sub>2</sub></sub> >70%<br>
| |
| ❑ Hemoglobin >7–9 g/dL<br>
| |
| ❑ Lactate <2.2 mM/L<br>
| |
| ❑ Urine output >0.5 mL/kg/h}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
| |
| {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: center; height: 40px; | | | | | | | | | | | | | B06 | | | | | | | | | | | | | |B06=
| |
| '''Classify and treat accodringly'''}}
| |
| {{Family tree/end}}
| |
|
| |
| <sup>†</sup> For septic and hypovolemic shock; consider normal saline 100—200 mL boluses for cardiogenic shock.
| |
|
| |
| ==References==
| |
|
| |
| {{reflist|2}}
| |